Aileron protein delivery tech lands potential $1bn Roche deal
Cell penetration and pharmacodynamics boosting “stapled peptide” tech wins Aileron Therapeutics potential billion dollar protein drug development deal with Roche.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs